Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Professional Survey 2023
This report studies the global 23-Valent Pneumococcal Polysaccharide Vaccine market status and forecast, categorizes the global 23-Valent Pneumococcal Polysaccharide Vaccine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China and other regions (India, Southeast Asia, Central & South America, and Middle East & Africa).
23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.
23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
North America is the largest supplier and consumption market of 23-Valent Pneumococcal Polysaccharide Vaccine, with a production market share nearly 70% and sales market share nearly 28% in 2015. Because Sanofipasteur, a competitor from Europe, transferred its vaccine type gradually, the production market share of North America in the world has enjoyed a dramatic increase.
The second place is EU, following North America with production market share of 15% and sales market share nearly 20% in 2015.China is another important market of 23-Valent Pneumococcal Polysaccharide Vaccine, enjoying 10% production market share and 15% sales market share in 2015.
The global 23-Valent Pneumococcal Polysaccharide Vaccine market is valued at 1550 million US$ in 2017 and will reach 4550 million US$ by the end of 2025, growing at a CAGR of 14.4% during 2018-2025.
The major manufacturers covered in this report
MSD
Sanofipasteur
CDIBP
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India
Other Regions (India, Southeast Asia, Central & South America and Middle East & Africa)
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Single Dose Vial
Pre-filled Syringe
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
For Children (2-10)
For Person (10-64)
For The Old (≥65)
The study objectives of this report are:
To analyze and study the global 23-Valent Pneumococcal Polysaccharide Vaccine capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of 23-Valent Pneumococcal Polysaccharide Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers
23-Valent Pneumococcal Polysaccharide Vaccine Distributors/Traders/Wholesalers
23-Valent Pneumococcal Polysaccharide Vaccine Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the 23-Valent Pneumococcal Polysaccharide Vaccine market, by end-use.
Detailed analysis and profiles of additional market players.
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2018
1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type (Product Category)
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share by Type (Product Category) in 2017
1.2.3 Single Dose Vial
1.2.4 Pre-filled Syringe
1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
1.3.1 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (≥65)
1.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market by Region (2013-2025)
1.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 Status and Prospect (2013-2025)
1.4.3 25 Status and Prospect (2013-2025)
1.4.4 North America Status and Prospect (2013-2025)
1.4.5 Europe Status and Prospect (2013-2025)
1.4.6 China Status and Prospect (2013-2025)
1.4.7 Japan Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of 23-Valent Pneumococcal Polysaccharide Vaccine (2013-2025)
1.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Status and Outlook (2013-2025)
1.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production Status and Outlook (2013-2025)
2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Competition by Manufacturers
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production and Share by Manufacturers (2013-2018)
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Share by Manufacturers (2013-2018)
2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturers (2013-2018)
2.4 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Sales Area and Product Type
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.5.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity and Market Share by Region (2013-2018)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production and Market Share by Region (2013-2018)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Region (2013-2018)
4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export, Import (2013-2018)
4.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export, Import (2013-2018)
4.4 China 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export, Import (2013-2018)
4.5 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export, Import (2013-2018)
4.7 India 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export, Import (2013-2018)
4.7 India 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export, Import (2013-2018)
4.8 South America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export, Import (2013-2018)
4.9 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export, Import (2013-2018)
5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue (Value), Price Trend by Type
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production and Market Share by Type (2013-2018)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2013-2018)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2013-2018)
5.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth by Type (2013-2018)
6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis by Application
6.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Market Share by Application (2013-2018)
6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Profiles/Analysis
7.1 MSD
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Sanofipasteur
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 CDIBP
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
8 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
8.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2018-2025)
12.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price and Trend Forecast (2018-2025)
12.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue and Price Forecast by Type (2018-2025)
12.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2018-2025)
12.3.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2018-2025)
12.3.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2018-2025)
12.3.4 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2018-2025)
12.3.5 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2018-2025)
12.3.6 India 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2018-2025)
12.3.7 South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2018-2025)
12.3.8 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2018-2025)
12.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production, Revenue and Price Forecast by Type (2018-2025)
12.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Single Dose Vial
Table Major Manufacturers of Single Dose Vial
Figure Product Picture of Pre-filled Syringe
Table Major Manufacturers of Pre-filled Syringe
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) by Applications (2013-2025)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Applications in 2017
Figure For Children (2-10) Examples
Table Key Downstream Customer in For Children (2-10)
Figure For Person (10-64) Examples
Table Key Downstream Customer in For Person (10-64)
Figure For The Old (≥65) Examples
Table Key Downstream Customer in For The Old (≥65)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Million USD), Comparison (K Dose) and CAGR (%) by Regions (2013-2025)
Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose) Status and Outlook (2013-2025)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Players Product Capacity (K Dose) (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity (K Dose) of Key Manufacturers (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity (K Dose) of Key Manufacturers in 2017
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity (K Dose) of Key Manufacturers in 2018
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Players Product Production (K Dose) (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) of Key Manufacturers (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Share by Manufacturers (2013-2018)
Figure 2017 23-Valent Pneumococcal Polysaccharide Vaccine Production Share by Manufacturers
Figure 2017 23-Valent Pneumococcal Polysaccharide Vaccine Production Share by Manufacturers
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Players Product Revenue (Million USD) (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Manufacturers (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2013-2018)
Table 2017 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers
Table 2018 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers
Table Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Dose) of Key Manufacturers (2013-2018)
Figure Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Dose) of Key Manufacturers in 2017
Table Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution and Sales Area
Table Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Category
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 Manufacturers
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 5 Manufacturers
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity (K Dose) by Region (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity Market Share by Region (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity Market Share by Region (2013-2018)
Figure 2017 Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity Market Share by Region
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production by Region (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) by Region (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share by Region (2013-2018)
Figure 2017 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share by Region
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Region (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2013-2018)
Table 2017 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose) and Growth Rate (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table China 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Japan 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table India 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Market by Region (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Region (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Region (2013-2018)
Figure 2017 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Market Share by Region
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Import & Export (K Dose) (2013-2018)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Import & Export (K Dose) (2013-2018)
Table China 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Import & Export (K Dose) (2013-2018)
Table Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Import & Export (K Dose) (2013-2018)
Table Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Import & Export (K Dose) (2013-2018)
Table India 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Import & Export (K Dose) (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) by Type (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Share by Type (2013-2018)
Figure Production Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2013-2018)
Figure 2017 Production Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) by Type (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2013-2018)
Figure Production Revenue Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2013-2018)
Figure 2017 Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose) by Type (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth by Type (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) by Application (2013-2018)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Applications (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application in 2017
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate by Application (2013-2018)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth Rate by Application (2013-2018)
Table MSD Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose), Revenue (Million USD), Price (MSD) and Gross Margin (2013-2018)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2013-2018)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share (2013-2018)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share (2013-2018)
Table Sanofipasteur Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2013-2018)
Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share (2013-2018)
Figure Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share (2013-2018)
Table CDIBP Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Production Growth Rate (2013-2018)
Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share (2013-2018)
Figure CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Table Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2017
Table Major Buyers of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Distributors/Traders List
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity, Production (K Dose) and Growth Rate Forecast (2018-2025)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (Million USD) and Trend Forecast (2018-2025)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) Forecast by Region (2018-2025)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Market Share Forecast by Region (2018-2025)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Forecast by Region (2018-2025)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share Forecast by Region (2018-2025)
Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) and Growth Rate Forecast (2018-2025)
Figure North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export and Import (K Dose) Forecast (2018-2025)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) and Growth Rate Forecast (2018-2025)
Figure Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export and Import (K Dose) Forecast (2018-2025)
Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) and Growth Rate Forecast (2018-2025)
Figure China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export and Import (K Dose) Forecast (2018-2025)
Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) and Growth Rate Forecast (2018-2025)
Figure Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan 23-Valent Pneumococcal Polysaccharide Vaccine Production, Consumption, Export and Import (K Dose) Forecast (2018-2025)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) Forecast by Type (2018-2025)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Production (K Dose) Forecast by Type (2018-2025)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2018-2025)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2018-2025)
Table Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Forecast by Application (2018-2025)
Figure Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption (K Dose) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
Research Methodology
The research study released with title "Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Professional Survey 2023" involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Key Executives Interviewed
Research Programs/Design
| Historical Data (2017-2022E) |
|
|
| Market Factor Analysis |
|
|
| Market Forecast (2023F-2028F) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate and estimate the global/regional market size by manufacturers, regional splits, product segments and application.
To establish Research coverage of the study with most relevant & functional players HTF MI follows industry standards such as NAICS/SIC/ICB/TRCB, furthermore the sorted list of companies is validated using Product Mapping and business activities and shortlisted by industry perspective.
HTF MI select experienced analyst and associate that are specialized in the domain for conducting research. They prepare a list of companies by region that helps to understand players penetration rate in the market. This companies are further analyses in what segment or application they serve in our market. The list of product and applications are evaluated for each companies dealing in the Global 23 Valent Pneumococcal Polysaccharide Vaccine Market report. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global. Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Online) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc from Global 23 Valent Pneumococcal Polysaccharide Vaccine Market report who then work towards appointment generation.
Primary Data Collection
The primary research is performed by taking the interviews of executives of various companies dealing in the Global 23 Valent Pneumococcal Polysaccharide Vaccine Market report as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and relevant list of appointee or target primary respondents; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & In Mail, Community Forums, Open Survey, SurveyMonkey etc.
Secondary Sources
The secondary resources considered in the Global 23 Valent Pneumococcal Polysaccharide Vaccine Market report study includes company annual reports, press releases, published articles of organizations and associations, and the survey taken through different mediums such as online website and forums, survey monkey, LinkedIn, etc. In addition, the valuable strategic information obtained from industry association, paid database, and investor presentations are also good tool for information to make appropriate iterative validation are used to modify market models and cross-verify primary research and insights.
Market Breakdown and Data Triangulation
To make market engineering data complete; extensive primary research is conducted to gather information and validate the critical numbers derived to be used for calculations of market statistics; market size estimations; forecasting; breakdown; and data triangulation. Both top-down and bottom-up approaches were applied, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Furthermore qualitative and further quantitative analysis is also done for all the numbers arrived at in the market estimation process to list relevant information in the final deliverable report "Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Professional Survey 2023" .
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Key Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments |
|
|
| Total Market |
|
|
| Format | Properties | |
|---|---|---|
| 1-User Access | The report is sent in PDF format. The report will be emailed to you. | This is a single user access license, allowing one specific user to access the report. |
| Site User | The study would be provided in PDF format. The report will be emailed to you. | This is a site license, allowing 1-10 employees within your organisation to access the report. |
| Enterprise User | The format of deliverable would be PDF and Excel. | This is an enterprise or corporate license, allowing all employees within your organisation irrespective of geographic location to access the report. |
